secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vera Therapeutics, Inc. (VERA)
CIK:        0001831828
Form:       8-K
Filed at:   2024-06-12T23:59:59+00:00
Accession:  0001193125-24-159935
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Vera Therapeutics appoints Christy Oliger to board; grants 25K share options
----------------------------------------------------------------------------

- Christy Oliger appointed as Class III Director effective June 7, 2024, term through 2027 annual meeting.
- Received nonstatutory stock option for 25,000 shares vesting monthly over three years.
- Annual cash retainer of $40,000 for board service plus $4,000 for Nominating Committee, prorated for 2024.
- Awarded 2,987 restricted stock units, fully vested for prior consulting services, settling in 2025.
- Will serve on Nominating and Corporate Governance Committee.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1831828/000119312524159935/0001193125-24-159935-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1831828/000119312524159935/d843919d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-159935

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer